Company / Return on Assets (ROA)
ARS Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-52.3%
FY2025
5-year range
-52.3% / 2.3%
FY2021-FY2025
Trend
-2393.0%
vs FY2024
Sector context
#178 of 213
Health Care
What the data says
Return on Assets (ROA) changed -2393% YoY in FY2025, a notable deviation from the 5-year average annual change of -545%.
Based on SEC 10-K filings.
-52.3% in FY2025 with a 5-year CAGR of -43.9%.
Declined from -23.3% to -52.3% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -45.1pp
- 5-Year Change
- -43.9pp
- 10-Year Change
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 213This company -52.3% Sector average -24.1%
▼
-116.6% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 2393.0% year-over-year.
- Currently 28.1pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -52.3% | -2393.0% |
| FY2024 | 2.3% | +109.8% |
| FY2023 | -23.3% | -224.2% |
| FY2022 | -7.2% | +78.2% |
| FY2021 | -32.9% | -294.5% |
| FY2020 | -8.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026